RxSight, Inc. reports results for the quarter ended June 30 - Earnings Summary

RxSight

05/08/2026 22:57

RxSight, Inc. RXST.OQ reported a quarterly adjusted loss of 29 cents​​ per share for the quarter ended June 30, identical to the same quarter last year.  The mean expectation of ten analysts for the quarter was for a loss of 33 cents per share. Wall Street expected results to range from -40 cents to -14 cents per share.
Revenue rose 0.3% to $33.74 million from a year ago; analysts expected $32.55 million. 
RxSight, Inc.'s reported EPS for the quarter was a loss of 29 cents​.
The company reported a quarterly loss of $12.1 million.
RxSight, Inc. shares had risen by 29.7% this quarter and lost 40.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 2.9% in the last three months.​ 
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 7 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."
Wall Street's median 12-month price target for RxSight, Inc. is $8.00, about 21.9% above its last closing price of $6.25
This summary was machine generated from LSEG data August 5 at 09:57 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.33
-0.29
Beat
Mar. 31 2026 
-0.28
-0.38
Missed
Dec. 31 2025 
-0.33
-0.22
Beat
Sep. 30 2025 
-0.38
-0.24
Beat